Adenovirus Vector Recombinant Vaccine for COVID-19

· Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adenovirus Vector Recombinant Vaccine for COVID-19, covering 2023-05-24 to 2023-05-24. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) [Phase 2]

See pricing